Free Trial
NASDAQ:MDXH

MDxHealth (MDXH) Stock Price, News & Analysis

MDxHealth logo
$2.40 +0.14 (+5.95%)
As of 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About MDxHealth Stock (NASDAQ:MDXH)

Key Stats

Today's Range
$2.29
$2.45
50-Day Range
$1.78
$2.40
52-Week Range
$1.35
$3.50
Volume
132,356 shs
Average Volume
91,068 shs
Market Capitalization
$113.50 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$7.00
Consensus Rating
Buy

Company Overview

MDxHealth Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
42nd Percentile Overall Score

MDXH MarketRank™: 

MDxHealth scored higher than 42% of companies evaluated by MarketBeat, and ranked 685th out of 933 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    MDxHealth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    MDxHealth has only been the subject of 1 research reports in the past 90 days.

  • Read more about MDxHealth's stock forecast and price target.
  • Earnings Growth

    Earnings for MDxHealth are expected to grow in the coming year, from ($1.15) to ($0.61) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MDxHealth is -2.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MDxHealth is -2.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    MDxHealth has a P/B Ratio of 7.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about MDxHealth's valuation and earnings.
  • Percentage of Shares Shorted

    0.25% of the float of MDxHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    MDxHealth has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MDxHealth has recently increased by 133.82%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    MDxHealth does not currently pay a dividend.

  • Dividend Growth

    MDxHealth does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.25% of the float of MDxHealth has been sold short.
  • Short Interest Ratio / Days to Cover

    MDxHealth has a short interest ratio ("days to cover") of 1.5, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in MDxHealth has recently increased by 133.82%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    MDxHealth has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.96 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for MDxHealth this week, compared to 1 article on an average week.
Receive MDXH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MDxHealth and its competitors with MarketBeat's FREE daily newsletter.

MDXH Stock News Headlines

MDxHealth (NASDAQ:MDXH) Shares Up 0.5% - Should You Buy?
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
MDxHealth CFO Kalfus Resigns
See More Headlines

MDXH Stock Analysis - Frequently Asked Questions

MDxHealth's stock was trading at $2.37 at the beginning of the year. Since then, MDXH shares have increased by 1.3% and is now trading at $2.40.

MDxHealth SA (NASDAQ:MDXH) announced its earnings results on Wednesday, May, 14th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.06. The business had revenue of $24.29 million for the quarter, compared to the consensus estimate of $22.62 million. MDxHealth had a negative net margin of 41.02% and a negative trailing twelve-month return on equity of 492.11%.
Read the conference call transcript
.

MDxHealth's stock reverse split on Friday, December 29th 2023.The 1-10 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, December 28th 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

MDxHealth (MDXH) raised $45 million in an initial public offering (IPO) on Thursday, November 4th 2021. The company issued 3,750,000 shares at $12.00 per share.

Shares of MDXH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that MDxHealth investors own include Cognition Therapeutics (CGTX), LAVA Therapeutics (LVTX), Coeptis Therapeutics (COEP), PHX Minerals (PHX), PayPal (PYPL), Arcadia Biosciences (RKDA) and Alimera Sciences (ALIM).

Company Calendar

Last Earnings
5/14/2025
Today
7/18/2025
Next Earnings (Estimated)
8/20/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
N/A
Current Symbol
NASDAQ:MDXH
CIK
1872529
Employees
300
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$6.00
Potential Upside/Downside
+191.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$38.07 million
Net Margins
-41.02%
Pretax Margin
-40.47%
Return on Equity
-492.11%
Return on Assets
-23.00%

Debt

Debt-to-Equity Ratio
13.81
Current Ratio
2.00
Quick Ratio
1.92

Sales & Book Value

Annual Sales
$90.05 million
Price / Sales
1.26
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.31 per share
Price / Book
7.74

Miscellaneous

Outstanding Shares
47,290,000
Free Float
46,484,000
Market Cap
$113.50 million
Optionable
Not Optionable
Beta
1.31
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:MDXH) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners